Legal but immoral: attitudes toward non-invasive brain stimulation for cognitive enhancement

preprint OA: closed CC-BY-NC-ND-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated deep summary by claude@2026-07, 2026-07-05 · read from full text

The paper investigates how university students judge the moral acceptability of cognitive enhancement in healthy individuals, comparing natural enhancers, pharmacological agents, and non-invasive brain stimulation (tDCS) across five moral domains (academic fairness, free will, naturalness, self-identity, and safety), using an online mixed-design experiment (n=449). Participants rated natural enhancers most positively, followed by brain stimulation and then pharmacological agents; despite being legal and marketed as non-invasive, brain stimulation was evaluated more similarly to pharmacological enhancement than to natural methods. The study also found framing effects, with greater acceptance when enhancement was described as preserving baseline ability rather than augmenting beyond it, and priming that emphasized others’ use reducing acceptability—especially for academic fairness regarding pharmacological and brain stimulation. The paper does not explicitly discuss clinical outcomes and is limited to students’ attitudes based on scenario-based judgments, rather than measuring real-world safety or cognitive performance. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Cognitive enhancement involves using substances or technologies to improve mental performance in healthy individuals. While methods such as caffeine are widely accepted, others, including prescription stimulants and non-invasive brain stimulation (tDCS), evoke ethical concern. This study examined how university students evaluate three forms of cognitive enhancement (natural, pharmacological, brain stimulation) across five moral domains: academic fairness, free will, naturalness, self-identity, and safety. We also tested how evaluations were shaped by framing (preservation vs. enhancement) and priming (self-affecting vs. non-self-affecting). A total of 449 students completed an online experiment with a 2 × 2 × 3 mixed design, rating enhancement acceptability after reading intervention-specific scenarios. Natural enhancers were judged most positively, followed by brain stimulation and then pharmacological agents. Importantly, although brain stimulation is legal and marketed as non-invasive, it was evaluated more like pharmacological enhancement than natural methods, indicating that legality does not equate to moral acceptability. Framing effects showed that participants were more accepting of enhancement when it was described as preserving ability rather than augmenting it beyond baseline. Priming participants to consider how others’ use might affect their own outcomes reduced moral acceptability, particularly for pharmacological and brain stimulation methods in the domain of academic fairness. Overall, public attitudes toward enhancement appeared shaped less by legality or objective safety than by intuitive moral reasoning. These findings highlight the importance of adopting pluralistic, context-sensitive approaches to policy and regulation, as student judgments reflect concerns about fairness, authenticity, and competition in academic life.
Full text 1,959 characters · extracted from oa-doi-fallback · click to expand
Abstract Cognitive enhancement involves using substances or technologies to improve mental performance in healthy individuals. While methods such as caffeine are widely accepted, others, including prescription stimulants and non-invasive brain stimulation (tDCS), evoke ethical concern. This study examined how university students evaluate three forms of cognitive enhancement (natural, pharmacological, brain stimulation) across five moral domains: academic fairness, free will, naturalness, self-identity, and safety. We also tested how evaluations were shaped by framing (preservation vs. enhancement) and priming (self-affecting vs. non-self-affecting). A total of 449 students completed an online experiment with a 2 × 2 × 3 mixed design, rating enhancement acceptability after reading intervention-specific scenarios. Natural enhancers were judged most positively, followed by brain stimulation and then pharmacological agents. Importantly, although brain stimulation is legal and marketed as non-invasive, it was evaluated more like pharmacological enhancement than natural methods, indicating that legality does not equate to moral acceptability. Framing effects showed that participants were more accepting of enhancement when it was described as preserving ability rather than augmenting it beyond baseline. Priming participants to consider how others’ use might affect their own outcomes reduced moral acceptability, particularly for pharmacological and brain stimulation methods in the domain of academic fairness. Overall, public attitudes toward enhancement appeared shaped less by legality or objective safety than by intuitive moral reasoning. These findings highlight the importance of adopting pluralistic, context-sensitive approaches to policy and regulation, as student judgments reflect concerns about fairness, authenticity, and competition in academic life. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-27T02:00:06.600101+00:00
License: CC-BY-NC-ND-4.0